V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Row
E
ETONAI Stock Diagnostic Report

Eton Pharmaceuticals CBO David Krempa sells $229k in stock

The fact that David Krempa, Chief Business Officer (CBO) of Eton Pharmaceuticals, sold approximately $229,000 worth of company stock can be interpreted as a negative signal.

View Source Article ↗
AI CATALYST SCORE30 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

ETON Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-10-11 08:45:43ETON30RowView Report →
2026-08-24 13:47:35ETON85S-ClassView Report →
2026-08-14 13:43:04ETON85S-ClassView Report →
View Full History for ETON (Blueprint) →